Logo

Charles Wagner, Anthony Mattachione

May 20, 2015

Charles Wagner has resigned as executive vice president and CFO at Bruker, effective June 12, in order to become the CFO of Ortho-Clinical Diagnostics. Bruker said that it intends to initiate a search for Wagner's replacement. Anthony Mattacchione, senior vice president of finance and accounting at Bruker, will serve as interim CFO upon Wagner's departure. 

Wagner became CFO of Bruker in 2012. Before that, he was a board member at the company. Prior to joining Bruker, he was CFO of Millipore, now EMD Millipore and part of Merck KGaA. 

Breaking News
The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.